These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33480428)

  • 1. Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer.
    Takemoto S; Shibamoto Y; Hashizume C; Miyakawa A; Murai T; Yanagi T; Sugie C; Nagai A
    J Radiat Res; 2021 Mar; 62(2):338-345. PubMed ID: 33480428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.
    Vekens K; Verbanck S; Collen C; Storme G; Barbé K; De Ridder M; Vanderhelst E
    Strahlenther Onkol; 2020 Feb; 196(2):142-150. PubMed ID: 31300831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival.
    Stone B; Mangona VS; Johnson MD; Ye H; Grills IS
    J Thorac Oncol; 2015 Dec; 10(12):1762-9. PubMed ID: 26334751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Boersma LJ; Muller SH; Baas P; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1331-40. PubMed ID: 12654445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
    Marks LB; Munley MT; Bentel GC; Zhou SM; Hollis D; Scarfone C; Sibley GS; Kong FM; Jirtle R; Jaszczak R; Coleman RE; Tapson V; Anscher M
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):563-70. PubMed ID: 9336133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.
    Wang J; Cao J; Yuan S; Ji W; Arenberg D; Dai J; Stanton P; Tatro D; Ten Haken RK; Wang L; Kong FM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):798-804. PubMed ID: 22836048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.
    Stanic S; Paulus R; Timmerman RD; Michalski JM; Barriger RB; Bezjak A; Videtic GM; Bradley J
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1092-9. PubMed ID: 24661663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
    Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Machuzak M; Mazzone P; Videtic GM
    J Thorac Oncol; 2009 Jul; 4(7):838-44. PubMed ID: 19487961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months.
    Navarro-Martin A; Aso S; Cacicedo J; Arnaiz M; Navarro V; Rosales S; de Blas R; Ramos R; Guedea F
    J Thorac Oncol; 2016 Jul; 11(7):1101-11. PubMed ID: 27103512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study.
    Jaén J; Vázquez G; Alonso E; León A; Guerrero R; Almansa JF
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1381-8. PubMed ID: 16757130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary function testing after stereotactic body radiotherapy to the lung.
    Bishawi M; Kim B; Moore WH; Bilfinger TV
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e107-10. PubMed ID: 21470798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting postoperative pulmonary function in patients undergoing lung resection.
    Zeiher BG; Gross TJ; Kern JA; Lanza LA; Peterson MW
    Chest; 1995 Jul; 108(1):68-72. PubMed ID: 7606994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
    Borst GR; De Jaeger K; Belderbos JS; Burgers SA; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):639-44. PubMed ID: 15936539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II).
    Bucknell NW; Hardcastle N; Bressel M; Moore A; Montgomery R; Murnane A; Mai GT; Ball D; Kron T; Siva S
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):944-951. PubMed ID: 37871885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.
    Ishihara T; Yamada K; Harada A; Yukiue H; Tanahashi M; Niwa H; Matsui T; Yokomura K; Ejima Y; Sasaki R
    Acta Oncol; 2018 Sep; 57(9):1232-1239. PubMed ID: 29722594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
    Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
    Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.